Metropolis Healthcare shares rise 3% after acquiring Core Diagnostics

Shares of diagnostic firm Metropolis Healthcare surged 2.88 per cent at Rs 2,250 per share on the BSE in Tuesday's intraday trade

Metropolis Healthcare
Representational Image
SI Reporter New Delhi
2 min read Last Updated : Dec 10 2024 | 11:21 AM IST
Shares of diagnostic firm Metropolis Healthcare surged 2.88 per cent at Rs 2,250 per share on the BSE in Tuesday’s intraday trade. This came after the company on Monday , announced today the acquisition of Delhi headquartered Core Diagnostics. 
 
Metropolis Healthcare said that the acquisition will enhance capabilities in advanced cancer testing, while deepening its presence in Northern and Eastern India and driving market share expansion in the specialised segment across the country. 
 
Metropolis is set to acquire a 100 per cent stake in Core Diagnostics through a combination of cash and stock, financing 55 per cent of the transaction in cash and 45 per cent through an equity swap, totalling Rs 246.8 crores. 
 
Core Diagnostics registered revenue of Rs 110 crores in FY2023-24. The equity issuance is subject to shareholder approval, and the acquisition is expected to be completed within 60 days, the company said in a statement. 
 
“Indian Oncology (cancer) market, which is expected to expand at a CAGR of 17.5 per cent from 2023 to 2028.With approximately 1.4 million new cancer cases and nearly a million deaths annually in India, there is a critical need for advanced cancer testing nationwide. By integrating Core’s expertise and infrastructure with Metropolis' established strengths, we aim to reinforce our leadership in advanced cancer testing and establish a Centre of Excellence in Cancer Diagnostics” said Ameera Shah, promoter and executive chairperson, Metropolis Healthcare.
 
Metropolis Healthcare’s share price history
 
On the equities side, Metropolis Healthcare’s stock outperformed the market year to date as it has surged 31 per cent, while gaining 32 per cent in the last one year. In comparison BSE Sensex has risen 12 per cent year to date and 16 per cent in a year. 
 
The company has a total market capitalisation of Rs 11,258.05. Its shares are trading at a price to earnings multiple of 85.25 times and at an earning per share of 25.76.  
 
At 11:13 AM; the shares of the company were trading 0.41 per cent higher at Rs 2,195.95 a piece. By comparison, the BSE’s Sensex was up 0.12 per cent at 81,602.83 level. 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Buzzing stocksMetropolis HealthcareMarkets Sensex NiftyBSE NSEMarket news

First Published: Dec 10 2024 | 11:19 AM IST

Next Story